Welcome to the Starpharma Investor Centre

Starpharma Holdings Limited is an Australian stock exchange listed biotechnology company with products based on its dendrimer technology platform.

asx.jpg

View All
ASX Announcements

 

Update your
shareholder details

 

Download 
Annual Report

View 
Analyst coverage

 

Submit an Investor query

 

Register for email updates

2023 Annual General Meeting

       

Latest News & Announcements

Click here for news archive

Starpharma to present DEP® at Radiopharmaceuticals Summit (ASX Announcement)

Dec 6th, 2023

Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it is presenting at the Targeted Radiopharmaceuticals Summit Europe, having been invited to present at the specialist radiotheranostics conference being held in Berlin, Germany, from 5 to 7 December 2023.

Read More

Notice of Annual General Meeting 2023 - Clarification (ASX Announcement)

Nov 15th, 2023

Starpharma refers to its Notice of Annual General Meeting dated 27 October 2023 (Notice).

Read More

 

Reports & Presentations

Click here for financial reports archive

Starpharma to present DEP® at Radiopharmaceuticals Summit (ASX Announcement)

Dec 6th, 2023

Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it is presenting at the Targeted Radiopharmaceuticals Summit Europe, having been invited to present at the specialist radiotheranostics conference being held in Berlin, Germany, from 5 to 7 December 2023.

Read More

Results of 2023 Annual General Meeting (ASX Announcement)

Nov 30th, 2023

Melbourne, Australia; 29 November 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) announces the details of the resolutions and the proxies and votes received in respect of each resolution at its Annual General Meeting (AGM) held today in accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, as set out in the attached proxy and voting summary. ... View/download... Read More